Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Bpifrance supplied funding through three separate units to help take Satt Conectus-allied rare disease drug developer Dynacure's latest round to $55m.

Illumina was among the returning investors for the round that will help Columbia spinout Kallyope prepare a weight loss treatment for clinical trials.

The urban airborne vehicle spinout of TU Munich closed more than $240m in funding, in a Tencent-led round reportedly valuing it at up to $1bn.

Insurance technology developer InsGeek, whose shareholders already include Tsinghua University-linked THG Ventures and TusStar, has added $25m in series C funding to its coffers.

Uday Kumar, whose previous spinout iRhythm is trading with a market cap of $2.6bn, has collected $145.6m in a GV-backed round for his latest venture.

Biotalys, a bio-fungicide and pesticide developer based on VIB technology previously known as AgroSavfe, has added $11m to its series C round.

Pliant Therapeutics has attracted $100m in a series C round led by Novartis, four years after it was founded to commercialise UC San Francisco research into fibrosis treatment.

GV and Intel Capital returned to reinvest in the computing technology provider, which was co-founded by Stanford professors and has now raised more than $450m altogether.

Inventec Appliances Corp has contributed to a round that will enable USF-founded Molekule to further develop and scale its air purification technology.